CNTX Context Therapeutics Inc.: institutional ownership and insider trading
89 funds reported holding $48.4M of Context Therapeutics Inc. in their latest 13F filings; in Q2 2026 funds net sold $6.33M, with 36 new positions and 17 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Famous investors holding CNTX
- Renaissance Technologies (Renaissance Technologies): $577K, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $81.6K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $14.4K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $9.60K, 0.0% of the portfolio
Largest institutional holders of CNTX
- Nextech Invest Ltd. — $7.79M
- VANGUARD GROUP INC — $5.57M
- Nextech Invest, Ltd. — $4.11M
- Deep Track Capital, LP — $4.11M
- Soleus Capital Management, L.P. — $3.91M
- BlackRock, Inc. (BLK) — $3.42M
- Avidity Partners Management LP — $2.77M
- FRANKLIN RESOURCES INC (BEN) — $2.11M
- VANGUARD CAPITAL MANAGEMENT LLC — $1.90M
- Octagon Capital Advisors LP — $1.69M
Recent CNTX insider trades
- Jun 9, 2025: Lehr Martin A. bought 100,000 shares ($70.0K)
- Jun 6, 2025: Levit Alex C. bought 20,000 shares ($11.6K)
- Jun 6, 2025: Minai-Azary Jennifer Lynn bought 40,010 shares ($25.6K)
5%+ owners
- Avidity Partners Management LP: 8.7% (Schedule 13G/A, filed May 12, 2026)
- Soleus Capital Master Fund, L.P.: 7.6% (Schedule 13G/A, filed May 8, 2026)
- BlackRock, Inc.: 6.7% (Schedule 13G, filed Jul 27, 2026)